Description

Pioglitazone HCI with Metformin HCI Sustained Release and Glimepiride Table

Composition:

Each uncoated bilayered tablet contains :

Pioglitazone Hydrochloride IP

equivalent to Pioglitazone    15 mg

Metformin Hydrochloride IP      500 mg

(as Sustained Release)

Glimepiride IP      1 mg

Colour : Quinoline Yellow

INDICATION & USE

• Diabetes Mellitus

• Diabetes with Obesity